Currently Enrolling Clinical Trials for IBC
Currently Enrolling Clinical Trials for IBC (designed for IBC patients or building on IBC [...]
Ruxolitinib + chemo upfront TN-IBC
Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as [...]
How To Navigate
Pick a trial on the previous screen and scroll to bottom to choose a [...]
Eribulin-AC HER2- IBC
Alternative Drug Names: Eribulin is also known as Halaven (US brand name) and previously [...]
ACE for metastatic IBC
Alternative Drug Names: Atezolizumab is also known as Tecentriq. Cobimetinib is also known as [...]
Adjuvant Keytuda ER+ stage 3 IBC
Alternative Drug Names: Keytruda is the brand name for Pembrolizumab. It used to be [...]
IBC Skin Metastases Project
Our purpose is to fund research. We met Ria, and her project in Dr. Kenneth [...]
PLX-3397 + MK-3475 Dual Immunotherapy
Alternative Drug Names: PLX-3397 is also called Pexidartinib. MK-3475 is now Pembrolizumab (Keytruda brand [...]
Dual HER2 + Abraxane
Alternative Drug Names: Nab-Paclitaxel (Abraxane brand in the US), Trastuzumab (Herceptin is the brand [...]
Ruxolitinib + Paclitaxel IBC
Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as [...]
Dual HER2 + chemo upfront IBC
Alternative Drug Names: Paclitaxel (Taxol brand in the US and abroad), Trastuzumab (Herceptin is [...]
Nintedanib IBC
Alternative Drug Names: Nintedanib was called BIBF 1120 (Ofev brand in the US) Purpose [...]
MK-3475 (Keytruda) IBC
Alternative Drug Names: MK-3475 is now Pembrolizumab (Keytruda brand in the US) Purpose of [...]
IBC And Brain Metastases
IBC metastasizes to the brain in about 19% of IBC patients within the first 2 [...]
Romidepsin & Abraxane IBC
Alternative Drug Names: Romidepsin (Istodax brand in the US). Romidepsin is also known as [...]
Triple Negative Breast Cancer: From Bench to Clinic in 2013
A guest post by Dr Angela Alexander, a TRIUMPH translational postdoctoral fellow at MD Anderson. [...]